Wegovy is approved not only to reduce weight but to reduce a hard cardiovascular outcome and to treat a liver condition
For that, you may need to consider a lifestyle change, and if thats something you want to commit to alongside taking GLP-1 medications, then give Second Nature a try.
A Quick Reference for Non-Specialist Clinicians LIKELY APPROPRIATE BMI 35, no eating disorder history Type 2 diabetes + overweight Cardiovascular risk reduction Metabolic syndrome REQUIRES EATING DISORDER SPECIALIST CONSULT FIRST Binge eating disorder Any prior mental health diagnosis History of disordered eating Adolescents / young adults DO NOT PRESCRIBE / HIGH RISK Active anorexia nervosa Active restrictive eating disorder History of MTC or MEN2 Active pancreatitis A Note on Autonomy, Judgment, and What We Owe Our Patients The following reflects my personal opinion and clinical perspective
In addition to Ozempic and Wegovy, other prescription medications selected for negotiations include Calquence, Trelegy Ellipta, Rybelsus, Linzess and Otezla
Intramuscular injection is technically more demanding and carries greater risk than the subcutaneous route, so it should only be undertaken with proper training and a clear anatomical understanding of the chosen site
A 2020 paper published in the high-tier scientific journal Nature Communications reported the findings of the PREMOTE study, which evaluated the gut-microbiome-related effects of berberine and probiotics on Type 2 diabetes